CB

Carlos Bais

EVP, Chief Scientific Officer

Inhibrx Biosciences

Therapeutic Areas

Inhibrx Biosciences Pipeline

DrugIndicationPhase
ozekibart (INBRX-109)Ewing SarcomaPhase 1
INBRX-106Advanced Solid TumorsPhase 1/2